Italy· 045214018

CANDETENS

A candesartan und amlodipin product containing candesartan cilexetil + amlodipina, registered in Italy by SCHARPER S.P.A., on the national reimbursement list. The same ATC class is registered in 6 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC C09DB07

Checked against AIFA (Italy) on

Informational only — not a medical device.

SOURCE REGISTER · ITAIFA (Italy)normalisedCANDETENSATCC09DB07REGISTER NO.045214018PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Candesartan und amlodipin is registered in 6 of 19 countries.

Countries holding a registration under ATC C09DB07 (candesartan und amlodipin), each read from that country’s own register.

  • This record: Italy, from AIFA (Italy)
  • 6 of them publish a price we can compare per daily dose

Candesartan und amlodipin · ATC C09DB07

6 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Italyprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

AIFA (Italy)
Active substance
Candesartan cilexetil + Amlodipina
Manufacturer
SCHARPER S.P.A.
Country
Italy (IT)
ATC code
C09DB07
ATC class
Candesartan und Amlodipin
Reimbursed
Yes
Source register
AIFA (Italy)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • aic
    045214018
    "8 MG + 5 MG CAPSULE RIGIDE" 28 CAPSULE IN BLISTER PA/AL/PVC/AL
    EUR 7.58

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

8 interactions on record for candesartan und amlodipin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Candesartan und amlodipin · interactions on record

8 records

8 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fe3f586d-6c7b-4c56-aa1c-632102bb71f2
GET /v1/drugs/fe3f586d-6c7b-4c56-aa1c-632102bb71f2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"8 MG + 5 MG CAPSULE RIGIDE\" 28 CAPSULE IN BLISTER PA/AL/PVC/AL",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Candesartan cilexetil + Amlodipina",
  "reference_pack": "28 UNITA' (8+5) MG - USO ORALE",
  "public_price_eur": 7.58,
  "ssn_reference_price_eur": 7.58
}

See everything about candesartan und amlodipin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.